BioNTech SE (BNTX)
Pfizer and BioNTech’s COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19
Pfizer and BioNTech’s COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19
Pfizer Inc. - Pfizer and BioNTech’s COMIRNATY®Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19
Pfizer and BioNTech’s COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19
IFF et Reservas Votorantim signent un partenariat de bioprospection au Brésil
IFF en Reservas Votorantim ondertekenen een bioprospectiepartnerschap in Brazilië
IFF與Reservas Votorantim在巴西簽署生物探勘合作協議
IFF与Reservas Votorantim在巴西签署生物勘探合作协议
Veracyte Announces New Study Published in Cell Shows that Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate Cancer
Community Health Systems to Participate in the 2025 Wells Fargo Healthcare Conference